Harvest Capital Management’s AbbVie ABBV Stock Holding History

Harvest Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$239K	Sell	3,296 -2,300	-41%	-$181K	0.07%	88
2019 Q1	$451K	Sell	5,596 -500	-8%	-$40.9K	0.14%	56
2018 Q4	$562K	Buy	6,096 +19	+0.3%	+$1.67K	0.21%	44
2018 Q3	$575K	Sell	6,077 -907	-13%	-$86K	0.18%	46
2018 Q2	$647K	Buy	6,984 +3,337	+91%	+$326K	0.22%	37
2018 Q1	$345K	Hold	3,647	–	–	0.13%	55
2017 Q4	$353K	Sell	3,647 -12	-0.3%	-$1.13K	0.13%	59
2017 Q3	$325K	Hold	3,659	–	–	0.13%	64
2017 Q2	$265K	Sell	3,659 -150	-4%	-$10.1K	0.11%	80
2017 Q1	$248K	Hold	3,809	–	–	0.1%	82
2016 Q4	$238K	Hold	3,809	–	–	0.1%	80
2016 Q3	$234K	Hold	3,809	–	–	0.11%	76
2016 Q2	$235K	Hold	3,809	–	–	0.11%	79
2016 Q1	$218K	Hold	3,809	–	–	0.1%	80
2015 Q4	$226K	Buy	+3,809	New	+$219K	0.1%	80
2015 Q1	–	Sell	-6,625	Closed	-$434K	–	84
2014 Q4	$434K	Sell	6,625 -75	-1%	-$4.73K	0.22%	40
2014 Q3	$387K	Hold	6,700	–	–	0.19%	50
2014 Q2	$378K	Buy	6,700 +200	+3%	+$10.5K	0.18%	50
2014 Q1	$334K	Hold	6,500	–	–	0.16%	54
2013 Q4	$343K	Hold	6,500	–	–	0.18%	52
2013 Q3	$291K	Hold	6,500	–	–	0.18%	60
2013 Q2	$269K	Buy	+6,500	New	+$284K	0.2%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Harvest Capital Management's ABBV Position: Q2 2019 in Review

Harvest Capital Management reduced its AbbVie (ABBV) stake by 41% in Q2 2019, selling an estimated $181K and leaving 3,296 shares worth $239K. The position accounts for 0.07% of the portfolio, ranked #88.

Harvest Capital Management first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. The position peaked at $647K in Q2 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Harvest Capital Management held 3,296 shares of AbbVie worth $239K as of Q2 2019.
Harvest Capital Management sold 2,300 AbbVie shares in Q2 2019, an estimated $181K.
AbbVie made up 0.07% of Harvest Capital Management's portfolio in Q2 2019, its #88 holding.
Harvest Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
Harvest Capital Management's AbbVie position peaked at $647K in Q2 2018.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Harvest Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.